PROTOCOL: New-Onset Diabetes Mellitus Post COVID-19 Infection: A Systematic Review and Meta-Analysis
Campbell Systematic Reviews: Better Evidence for a Better World · 2025-12 · 21 (4)
DOI: 10.1002/cl2.70069 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Campbell Systematic Reviews: Better Evidence for a Better World, online erschienen am 30.09.2025. Verfasst von Emma Cocking und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine The University of Notre Dame Australia Sydney New South Wales Australia. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Emerging evidence suggests that coronavirus disease 2019 (COVID-19) infection may cause diabetes mellitus in patients without a prior history of the condition.
Objective
This review aims to determine the incidence of new-onset diabetes mellitus in COVID-19 patients compared to individuals without COVID-19, including rates of diabetic ketoacidosis, hyperglycaemia, mortality, and intensive care unit admission. Subgroup analyses will investigate patients receiving corticosteroid therapy for COVID-19, patients admitted to hospital due to COVID-19, and the incidence of new-onset diabetes mellitus in relation to diabetes mellitus worldwide. The incidence of new-onset diabetes mellitus post-infection after a 6–12-month follow-up will also be reported.
Methods
This protocol follows the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines and is registered in PROSPERO (CRD42023457569). Eligible studies will include published and peer-reviewed cohort studies in English, after 1 December 2019. PubMed, Medline, Embase, and Scopus will be systematically searched. Included studies should compare new-onset diabetes mellitus incidence in COVID-19 patients against a control group without COVID-19. Two independent reviewers will extract data from included studies and assess risk of bias using the Newcastle-Ottawa quality assessment scale. A random-effects meta-analysis will compare the relative risk of new-onset diabetes mellitus post COVID-19 infection compared to non-infected individuals.
Conclusion
The findings of this review will contribute to understanding the bidirectional relationship between COVID-19 and diabetes mellitus and inform clinical management strategies for patients at risk. Systematic Review Registration PROSPERO CRD42023457569.
Autor:innen und Institutionen
- School of Medicine The University of Notre Dame Australia Sydney New South Wales Australia.
- Department of Medicine Gold Coast University Hospital Southport Queensland Australia.
ORCID-Profile: Emma Cocking
Zitieren
APA
Cocking, E., Daher, J., & Alabbood, M. (2025). PROTOCOL: New-Onset Diabetes Mellitus Post COVID-19 Infection: A Systematic Review and Meta-Analysis. Campbell Systematic Reviews: Better Evidence for a Better World, 21(4). https://doi.org/10.1002/cl2.70069
Vancouver
Cocking E, Daher J, Alabbood M. PROTOCOL: New-Onset Diabetes Mellitus Post COVID-19 Infection: A Systematic Review and Meta-Analysis. Campbell Systematic Reviews: Better Evidence for a Better World. 2025;21(4). doi:10.1002/cl2.70069
BibTeX
@article{Cocking2025,
author = {Cocking, Emma and Daher, Joseph and Alabbood, Majid},
title = {PROTOCOL: New-Onset Diabetes Mellitus Post COVID-19 Infection: A Systematic Review and Meta-Analysis},
journal = {Campbell Systematic Reviews: Better Evidence for a Better World},
year = {2025},
volume = {21},
number = {4},
doi = {10.1002/cl2.70069}
}
EUVIMED